Company / Cash & Equivalents
Healthier Choices Management Corp. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$1.1M
FY2025
5-year range
$1.1M / $26.5M
FY2021-FY2025
Trend
-4.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 3 consecutive years, from $26M in FY2021 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +4.3%.
Declined from $4M to $1M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 4.4% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
- Lowest cash & equivalents in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -62.55 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.1M | -4.4% |
| FY2024 | $1.2M | -67.4% |
| FY2023 | $3.7M | - |
| FY2022 | - | - |
| FY2021 | $26.5M | +2763.0% |
| FY2020 | $925.5K | -39.3% |
| FY2019 | $1.5M | -78.4% |
| FY2018 | $7.1M | -10.4% |
| FY2017 | $7.9M | -41.0% |
| FY2016 | $13.4M | -50.9% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026